Business
Business
Bots, Barrels, Banks, And Biopharma: Inside 2023’s Dividend Doldrums
The latest report from Dan Lefkovitz, strategist at Morningstar Indexes, examines dividend-stock underperformance in 2023....
Anna Peel
3 years















